insights_auto
Why is SOBI up 2.15%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 493.00
arrow_upward
+2.15%(+10.40) 1D
ኖቬም 5, 10:45:46 ጥዋት ጂ ኤም ቲ+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 486.00
High
SEK 494.00
Low
SEK 484.20
Mkt. cap
176.31 ቢ
Avg. vol.
337.83 ሺ
Volume
41.27 ሺ
P/E ratio
26.19
52-wk high
SEK 494.00
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64 ሚ
No. of employees
2 ሺ
Open
SEK 486.00
High
SEK 494.00
Low
SEK 484.20
Mkt. cap
176.31 ቢ
Avg. vol.
337.83 ሺ
Volume
41.27 ሺ
P/E ratio
26.19
52-wk high
SEK 494.00
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64 ሚ
No. of employees
2 ሺ
News stories
From web sources and news partners
TradingView
·
ከ1 ቀን በፊት
Swedish Orphan Biovitrum Executive Sells, Buys Shares
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)